A good journal for inquisitive people
N2 (38) 2014
The antitumor drug RL2, a genetically engineered analog of human milk protein lactaptin designed by a Novosibirsk research team, is now at the stage of preclinical trialsPharmacological modifiers of stem cells allow the structure of tissues and organs to be regenerated in the cases currently regarded as incurable Electrospinning has made it possible to create the polymeric prostheses for blood vessels almost as good in their properties as the natural prototype Tumor cells, deprived of an antiviral defense and intensively dividing, are an ideal target for viruses-
30.09.200435749
-
15.05.20185131
-
30.08.201080266
-
15.12.20114892
-
30.09.200435749
-
29.12.20203103
-
30.08.201080266
-
22.08.201213039
-
30.09.200435749
-
30.08.201080266
-
22.08.201213039
-
30.03.20069276
All articles
-
People
30.08.20144449 -
People
30.08.20142074 -
People
30.08.20144192 -
People
30.08.20143274 -
People
30.08.20143248 -
People
30.08.20141868 -
People
30.08.20142590 -
People
30.08.20142415 -
People
30.08.20144460 -
Faculty
30.08.20142804 -
People
30.08.20142240